| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |